Results 51 to 60 of about 1,262,741 (193)

Quality of life and marital sexual satisfaction in women with polycystic ovary syndrome.

Folia Histochemica et Cytobiologica, 2008
Polycystic ovary syndrome affects 5-10% of women in the developed world, making it the most common endocrine disorder among women of reproductive age. The symptoms typically associated with polycystic ovary syndrome: amenorrhea, oligomenorrhea, hirsutism,
Violetta Skrzypulec, Agnieszka Drosdzol, Barbara Mazur, Romana Pawlińska-Chmara   +3 more
doaj   +3 more sources

A comparison of the manifestation of psychopathic traits between women with and without Polycystic Ovary Syndrome (PCOS)

, 2022
Polycystic Ovary Syndrome (PCOS) impacts 5-10% of women of reproductive age and is characterized by increased testosterone, psychological distress, and dampened affect.
Sophie Williams, Dean Fido
core   +1 more source

The Polycystic Ovary Syndrome Quality of Life scale (PCOSQOL): Development and preliminary validation [PDF]

, 2018
Polycystic ovary syndrome is an endocrine disorder amongst women, which can negatively impact quality of life. Research proposes that a more sensitive PCOS quality of life measure is needed.
Sheffield, David, Sophie Williams, Knibb, Rebecca C, Knibb, Rebecca C., Rebecca C Knibb, Williams, Sophie, David Sheffield   +6 more
core   +1 more source

The Relationship between Follistatin and Chronic Low-Grade Inflammation in Women with Polycystic Ovary Syndrome

, 2011
The circulating follistatin and high-sensitivity C-reactive protein ( hsCRP) concentrations were significantly higher in 155 Taiwanese women with polycystic ovary syndrome (PCOS) than in 37 healthy controls.
CHEN, MEI-JOU;CHEN, HSIN-FU;CHEN, SHEE-UAN;HO, HONG-NERNG;YANG, YU-SHIH;YANG, WEI-SHIUNG, 陳美州;陳信孚;陳思原;何弘能;楊友仕;楊偉勛   +1 more
core   +1 more source

Cardiovascular risk of women with polycystic ovary syndrome

, 2006
Polycystic ovary syndrome (PCOS) is not only a reproductive problem but a complex, endocrine, multifaceted disease with several health complications.
COLAO, ANNAMARIA, Colao A, PALOMBA S, Orio F, PALOMBA, STEFANO, ORIO, Francesco, COLAO A.   +6 more
core   +1 more source

Pharmacological sympathetic denervation prevents the development of polycystic ovarian syndrome in rats injected with estradiol valerate

Reproductive Biology and Endocrinology, 2018
Background The injection of estradiol valerate in female rats induces polycystic ovary syndrome, which is characterized by polycystic ovaries, anovulation, and hyperandrogenism.
Julieta A. Espinoza, Wendy Alvarado, Berenice Venegas, Roberto Domínguez, Leticia Morales-Ledesma   +4 more
doaj   +1 more source

Value of ultrasonography in the diagnosis of polycystic ovary syndrome – literature review

, 2015
Polycystic ovary syndrome is a multi-factorial disease. Its etiopathogenesis has not been elucidated in detail. It is the most common endocrine disorder in women of child-bearing age.
Nebil Abdalla, Bachanek, Michał, Michał Bachanek, Krzysztof Cendrowski, Włodzimierz Sawicki, Cendrowski, Krzysztof, Sawicki, Włodzimierz, Abdalla, Nebil   +7 more
core   +1 more source

Polycystic ovary syndrome: clinical implication in perimenopause

, 2014
Polycystic ovary syndrome (PCOS), a hyperandrogenic disorder, is the commonest endocrinopathy in premenopausal women. This syndrome is associated with fertility problems, clinical manifestations of hyperandrogenism and metabolic disturbances ...
Ewa Woźniakowska, Janusz Solski, Tomasz Paszkowski, Monika Lenart-Lipińska, Jerzy S. Tarach, Beata Matyjaszek-Matuszek   +5 more
core   +1 more source

The anti-epileptic drug Valproic Acid (VPA) inhibits steroidogenesis in bovine theca and granulosa cells in vitro [PDF]

, 2012
Valproic acid (VPA) is used widely to treat epilepsy and bipolar disorder. Women undergoing VPA treatment reportedly have an increased incidence of polycystic ovarian syndrome (PCOS)-like symptoms including hyperandrogenism and oligo- or amenorrhoea.
Knight, PG, Michael Anthony E., Leanne Satchell, Glister, C, Philip G Knight, Michael, AE, Satchell, Leanne, Satchell, L, Knight Philip G., Bicknell, Andrew B., Anthony E Michael, Knight, Philip G., Satchell Leanne, Glister, Claire, Andrew B Bicknell, Michael, Anthony E., Bicknell, AB, Glister Claire, Claire Glister, Bicknell Andrew B.   +19 more
core   +2 more sources

The monocyte counts to HDL cholesterol ratio in obese and lean patients with polycystic ovary syndrome

Reproductive Biology and Endocrinology, 2018
Background Women with polycystic ovary syndrome are more likely to suffer from obesity, insulin resistance, and chronic low-grade inflammation. In fact, the excessive activation of monocytes exacerbates oxidative stress and inflammation.
Akin Usta, Eyup Avci, Cagla Bahar Bulbul, Hasan Kadi, Ertan Adali   +4 more
doaj   +1 more source